Coronary Artery Disease (CAD) and Atherosclerosis are complex cardiovascular conditions with significant global impact. Atherosclerosis, characterized by arterial plaque buildup, becomes a precursor to CAD. It involves the gradual buildup of arterial plaque, compromising blood flow to the heart. Plaque, primarily composed of cholesterol, fat, and other substances, accumulates within coronary arteries, leading to their narrowing and hardening.
In Atherosclerosis, inflammatory processes also trigger the formation of these plaques, initiating a cascade of events that compromise arterial flexibility. As plaque accumulates, the risk of blood clots and complete blockages rises, setting the stage for CAD. The global prevalence of CAD is alarming, affecting millions and contributing to heart attacks and related complications.
Atherosclerosis often progresses without noticeable symptoms in its early stages. Symptoms usually become apparent when the condition has advanced, leading to significant narrowing or blockage of arteries. The symptoms may vary depending on the affected arteries and organs and include:
Research on Coronary Artery Disease (CAD) and Atherosclerosis faces several challenges, reflecting the complex nature of these cardiovascular conditions. Key research challenges include:
Overcoming these challenges requires collaborative efforts from multidisciplinary research teams, innovative technologies, and a commitment to advancing scientific knowledge in cardiovascular research.
SCIRENT plays a pivotal role in conducting clinical trials that contribute to developing groundbreaking therapeutic approaches. Let us explore the possibilities of transformative research on Coronary Artery Disease and Atherosclerosis together!
